| Old Articles: <Older 47911-47920 Newer> |
|---|
 |
The Motley Fool
April 5, 2011
Andrew Bond |
Does Yahoo! Need an Acquisition Binge? Yahoo! may be jumping the gun.   |
The Motley Fool
April 5, 2011
Dan Caplinger |
This Company Wants to Win Your Wallet The way you pay is changing. This company wants to profit from it. |
The Motley Fool
April 5, 2011
Rick Aristotle Munarriz |
Expedia and American Fly Through the Turbulence Expedia and AMR make nice -- for now. |
The Motley Fool
April 5, 2011
Rick Aristotle Munarriz |
Blockbuster Is Dying Blockbuster's potential buyers may feel the place is worth more dead than alive. |
The Motley Fool
April 5, 2011
Cindy Johnson |
Cubist Pharmaceuticals Shares Popped: What You Need to Know Cubist Pharmaceuticals popped as much as 17% in intraday trading today after announcing a licensing agreement and the settlement of a patent dispute. |
The Motley Fool
April 5, 2011
Morgan Housel |
Goldman Sachs Vs. Angry Nuns God's work faces the wrath of God's Work. According to Guardian UK, a group of nuns is pushing Goldman Sachs to reconsider its pay practices |
The Motley Fool
April 5, 2011 |
Here's What Einhorn's Greenlight Capital Bought and Sold Last Quarter Top holdings and new trades for Greenlight Capital. |
The Motley Fool
April 5, 2011
Cindy Johnson |
National Semiconductor Shares Popped: What You Need to Know National Semiconductor popped 72% in intraday trading today after announcing a deal to be taken over by Texas Instruments. |
The Motley Fool
April 5, 2011
Matt Koppenheffer |
Could BP's Stock Double? Could embattled BP be a path to 100% returns? |
The Motley Fool
April 5, 2011
Frank Vinluan |
Tranzyme Pharma's Public Offering Raises $48M, but IPO Has Little Bounce Tranzyme Pharma likely had hopes for an opening bounce on the day the drug development company went public, but that ball fell flat. |
| <Older 47911-47920 Newer> Return to current articles. |
